Viscient Bio Revenue and Competitors
Estimated Revenue & Valuation
- Viscient Bio's estimated annual revenue is currently $1.9M per year.
- Viscient Bio's estimated revenue per employee is $155,000
Employee Data
- Viscient Bio has 12 Employees.
- Viscient Bio grew their employee count by -25% last year.
Viscient Bio's People
| Name | Title | Email/Phone |
|---|
Viscient Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Viscient Bio?
We are focused on utilizing 3D culture technology to develop drugs across a range of therapeutic areas. Founded by a combination of former Organovo and Ardea Biosciences scientists and entrepreneurs, Viscient is initially conducting discovery and development work in non-alcoholic fatty liver disease (“NAFLDâ€) and non-alcoholic steatohepatitis (“NASHâ€). Utilizing newly available three dimensional biology technologies, we explore biology in a previously unavailable context, leading to a better understanding of disease and an improved opportunity to impact patients.
keywords:N/A
N/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 12 | N/A | N/A |
#2 | $1M | 12 | N/A | N/A |
#3 | $1.2M | 12 | N/A | N/A |
#4 | $1M | 12 | N/A | N/A |
#5 | $1.4M | 12 | N/A | N/A |